Cargando…
A systematic quality rating of available mobile health apps for borderline personality disorder
BACKGROUND: Mobile health apps (MHAs) may offer a mean to overcome treatment barriers in Borderline Personality Disorder (BPD) mental health care. However, MHAs for BPD on the market lack transparency and quality assessment. METHODS: European app stores were systematically searched, and two independ...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9158356/ https://www.ncbi.nlm.nih.gov/pubmed/35642024 http://dx.doi.org/10.1186/s40479-022-00186-w |
_version_ | 1784718820102897664 |
---|---|
author | Steubl, Lena Sophia Reimann, Josephin Simon, Laura Terhorst, Yannik Stach, Michael Baumeister, Harald Sander, Lasse Bosse Messner, Eva-Maria |
author_facet | Steubl, Lena Sophia Reimann, Josephin Simon, Laura Terhorst, Yannik Stach, Michael Baumeister, Harald Sander, Lasse Bosse Messner, Eva-Maria |
author_sort | Steubl, Lena Sophia |
collection | PubMed |
description | BACKGROUND: Mobile health apps (MHAs) may offer a mean to overcome treatment barriers in Borderline Personality Disorder (BPD) mental health care. However, MHAs for BPD on the market lack transparency and quality assessment. METHODS: European app stores were systematically searched, and two independent trained reviewers extracted relevant MHAs. Employed methods and privacy and security details documentation of included MHAs were extracted. MHAs were then assessed and rated using the German version of the standardized Mobile Application Rating Scale (MARS-G). Mean values and standard deviations of all subscales (engagement, functionality, aesthetics, information, and therapeutic gain) and correlations with user ratings were calculated. RESULTS: Of 2977 identified MHAs, 16 were included, showing average quality across the four main subscales (M = 3.25, SD = 0.68). Shortcomings were observed with regard to engagement (M = 2.87, SD = 0.99), potential therapeutic gain (M = 2.67, SD = 0.83), existing evidence base (25.0% of included MHAs were tested empirically), and documented privacy and security details. No significant correlations were found between user ratings and the overall total score of the MARS-G or MARS-G main subscales. CONCLUSIONS: Available MHAs for BPD vary in quality and evidence on their efficacy, effectiveness, and possible adverse events is scarce. More substantial efforts to ensure the quality of MHAs available for patients and a focus on transparency, particularly regarding privacy and security documentation, are necessary. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40479-022-00186-w. |
format | Online Article Text |
id | pubmed-9158356 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-91583562022-06-02 A systematic quality rating of available mobile health apps for borderline personality disorder Steubl, Lena Sophia Reimann, Josephin Simon, Laura Terhorst, Yannik Stach, Michael Baumeister, Harald Sander, Lasse Bosse Messner, Eva-Maria Borderline Personal Disord Emot Dysregul Research Article BACKGROUND: Mobile health apps (MHAs) may offer a mean to overcome treatment barriers in Borderline Personality Disorder (BPD) mental health care. However, MHAs for BPD on the market lack transparency and quality assessment. METHODS: European app stores were systematically searched, and two independent trained reviewers extracted relevant MHAs. Employed methods and privacy and security details documentation of included MHAs were extracted. MHAs were then assessed and rated using the German version of the standardized Mobile Application Rating Scale (MARS-G). Mean values and standard deviations of all subscales (engagement, functionality, aesthetics, information, and therapeutic gain) and correlations with user ratings were calculated. RESULTS: Of 2977 identified MHAs, 16 were included, showing average quality across the four main subscales (M = 3.25, SD = 0.68). Shortcomings were observed with regard to engagement (M = 2.87, SD = 0.99), potential therapeutic gain (M = 2.67, SD = 0.83), existing evidence base (25.0% of included MHAs were tested empirically), and documented privacy and security details. No significant correlations were found between user ratings and the overall total score of the MARS-G or MARS-G main subscales. CONCLUSIONS: Available MHAs for BPD vary in quality and evidence on their efficacy, effectiveness, and possible adverse events is scarce. More substantial efforts to ensure the quality of MHAs available for patients and a focus on transparency, particularly regarding privacy and security documentation, are necessary. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40479-022-00186-w. BioMed Central 2022-06-01 /pmc/articles/PMC9158356/ /pubmed/35642024 http://dx.doi.org/10.1186/s40479-022-00186-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Steubl, Lena Sophia Reimann, Josephin Simon, Laura Terhorst, Yannik Stach, Michael Baumeister, Harald Sander, Lasse Bosse Messner, Eva-Maria A systematic quality rating of available mobile health apps for borderline personality disorder |
title | A systematic quality rating of available mobile health apps for borderline personality disorder |
title_full | A systematic quality rating of available mobile health apps for borderline personality disorder |
title_fullStr | A systematic quality rating of available mobile health apps for borderline personality disorder |
title_full_unstemmed | A systematic quality rating of available mobile health apps for borderline personality disorder |
title_short | A systematic quality rating of available mobile health apps for borderline personality disorder |
title_sort | systematic quality rating of available mobile health apps for borderline personality disorder |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9158356/ https://www.ncbi.nlm.nih.gov/pubmed/35642024 http://dx.doi.org/10.1186/s40479-022-00186-w |
work_keys_str_mv | AT steubllenasophia asystematicqualityratingofavailablemobilehealthappsforborderlinepersonalitydisorder AT reimannjosephin asystematicqualityratingofavailablemobilehealthappsforborderlinepersonalitydisorder AT simonlaura asystematicqualityratingofavailablemobilehealthappsforborderlinepersonalitydisorder AT terhorstyannik asystematicqualityratingofavailablemobilehealthappsforborderlinepersonalitydisorder AT stachmichael asystematicqualityratingofavailablemobilehealthappsforborderlinepersonalitydisorder AT baumeisterharald asystematicqualityratingofavailablemobilehealthappsforborderlinepersonalitydisorder AT sanderlassebosse asystematicqualityratingofavailablemobilehealthappsforborderlinepersonalitydisorder AT messnerevamaria asystematicqualityratingofavailablemobilehealthappsforborderlinepersonalitydisorder AT steubllenasophia systematicqualityratingofavailablemobilehealthappsforborderlinepersonalitydisorder AT reimannjosephin systematicqualityratingofavailablemobilehealthappsforborderlinepersonalitydisorder AT simonlaura systematicqualityratingofavailablemobilehealthappsforborderlinepersonalitydisorder AT terhorstyannik systematicqualityratingofavailablemobilehealthappsforborderlinepersonalitydisorder AT stachmichael systematicqualityratingofavailablemobilehealthappsforborderlinepersonalitydisorder AT baumeisterharald systematicqualityratingofavailablemobilehealthappsforborderlinepersonalitydisorder AT sanderlassebosse systematicqualityratingofavailablemobilehealthappsforborderlinepersonalitydisorder AT messnerevamaria systematicqualityratingofavailablemobilehealthappsforborderlinepersonalitydisorder |